维普中文期刊产品整合服务
11篇 您的检索式:作者名="Frevert EU"
    题名 作者 年代 出处 被引量
1Influence of renal or hepatic impairment on the pharmacokinetics of saxagliptin 显示文摘Boulton DW Li L Frevert EU 2011Clin Pharmacokinet2011,50,4:1
2Influence of renal or hepatic impairment on the pharmacokinetics of saxagliptin 显示文摘Boulton DW Li L Frevert EU 2011Clin Pharmacokinet2011,50,4:1
3Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes显示文摘 Frevert EU Kyder 1998Diabetes1998,47,:1
4Influence of renal or hepatic impairment on the pharmacokinetics of saxaglip- tin显示文摘Boulton DW Li L Frevert EU 2011Clin Pharmacokinet2011,50,4:1
5Influence of renal or hepatic impairment on the pharmacokinetics of saxagliptin显示文摘Boulton DW Li L Frevert EU 2011Clin Pharmacokinet2011,50,4:1
6Influence of renal or hepatic impairment on the pharmacokinetics of saxagliptin显示文摘Boulton DW Li L Frevert EU 2011Clin Pharmacokinet2011,50,4:1
7Influence of renal or hepatic impairment on the harmacokinetics of saxagliptin显示文摘Bouhon DW Li L Frevert EU 2011Clin Pharmacokinet2011,50,4:1
8Influence of re- nal or hepatic impairment on the pharmacokinetics of saxagliptin 显示文摘Boulton DW Li L Frevert EU 2011Clin Pharmacokinet2011,50,4:1
9Influence of renal or hepatic impairment on the pharmacokinetics of saxagliptin显示文摘Boulton DW Li L Frevert EU 2011Clin Pharmacokinet2011,50,4:1
10Influence of renal or hepatic impairment on the pharmacokinetics of saxagliptin显示文摘Boulton DW Li L Frevert EU 2011Clin Pharmacokinet2011,50,25:1
11Overexpression of protein-tyrosine phosphatase-lB in adipocytes inhibits insulin-stimulated phosphoinositide 3 - kinase activity without altering glucose transport or Akt/protein kinase B activation显示文摘Venable CL Frevert EU Kim YB 2000J Biol Chem2000,275,18:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费